Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 16:48

24,55 USD (-1,82%)

(-1,82%) 16:48

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d -1,82%
1 week1w -2,87%
1 maand1m -8,14%
3 maanden3m -15,27%
6 maanden6m 3,13%
1 jaar1j 21,69%
5 jaar5j -19,37%

donderdag 9 mei 2024, 13:00

Kwartaalcijfers (1ste kwartaal)

Insmed Inc in het nieuws

Toon enkel gratis nieuws

25 april 2024 · Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 · Persbericht

5 april 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

27 maart 2024 · Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference · Persbericht

5 maart 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

29 februari 2024 · Insmed To Present at Three March Conferences · Persbericht

28 februari 2024 · Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health · Persbericht

22 februari 2024 · Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update · Persbericht

8 februari 2024 · Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024 · Persbericht

2 februari 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

5 januari 2024 · Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

CEO: William Lewis

Werknemers: 778

Aandelen Insmed Inc

Beurswaarde: 3,71 miljard USD

Effecten: 148,56 miljoen

Winst per aandeel (12 maand): PLUS

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe